Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2,Condition 3,Condition 4
655,"De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90.",liver integrity trait,,RS:0001296,F344.BN-(D16Mit5-D16Rat75),male,0 days,N/A,,CMO:0001081,volume of liver occupied by tumorous lesions as percentage of total liver volume,,,,59,%,,9.0,MMO:0000220,ex vivo light microscopy with digital image analysis,,0.0,,N-nitrosodiethylamine injection at 200mg/kg,56,days,N-nitrosodiethylamine (200 mg/kg) (for 56 days),67438,N-nitrosodiethylamine (200 mg/kg) (for 56 days),,,
655,"De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90.",liver integrity trait,,RS:0001296,F344.BN-(D16Mit5-D16Rat75),male,0 days,N/A,,CMO:0001081,volume of liver occupied by tumorous lesions as percentage of total liver volume,,,,33,%,,8.0,MMO:0000220,ex vivo light microscopy with digital image analysis,,0.0,intraperitoneal,N-nitrosodiethylamine injection at 200mg/kg,56,days,orchiectomy then N-nitrosodiethylamine (200 mg/kg) (for 56 days),67442,orchiectomy,N-nitrosodiethylamine (200 mg/kg) (for 56 days),,
655,"De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90.",liver integrity trait,,RS:0001296,F344.BN-(D16Mit5-D16Rat75),male,0 days,N/A,,CMO:0001081,volume of liver occupied by tumorous lesions as percentage of total liver volume,,,,19,%,,5.4,MMO:0000220,ex vivo light microscopy with digital image analysis,,0.0,intraperitoneal,N-nitrosodiethylamine injection at 200mg/kg,56,days,orchiectomy then 17 beta-estradiol (3.3 mg/kg) (for 21 days) then N-nitrosodiethylamine (200 mg/kg) (for 56 days) then 17 beta-estradiol (10 mg/kg) (for 35 days),67446,orchiectomy,17 beta-estradiol (3.3 mg/kg) (for 21 days),N-nitrosodiethylamine (200 mg/kg) (for 56 days),17 beta-estradiol (10 mg/kg) (for 35 days)
655,"De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90.",liver integrity trait,,RS:0001296,F344.BN-(D16Mit5-D16Rat75),female,0 days,N/A,,CMO:0001081,volume of liver occupied by tumorous lesions as percentage of total liver volume,,,,10,%,,4.1,MMO:0000220,ex vivo light microscopy with digital image analysis,,0.0,,N-nitrosodiethylamine injection at 200mg/kg,56,days,N-nitrosodiethylamine (200 mg/kg) (for 56 days),67450,N-nitrosodiethylamine (200 mg/kg) (for 56 days),,,
655,"De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90.",liver integrity trait,,RS:0001296,F344.BN-(D16Mit5-D16Rat75),female,0 days,N/A,,CMO:0001081,volume of liver occupied by tumorous lesions as percentage of total liver volume,,,,19,%,,4.2,MMO:0000220,ex vivo light microscopy with digital image analysis,,0.0,intraperitoneal,N-nitrosodiethylamine injection at 200mg/kg,56,days,ovariectomy then N-nitrosodiethylamine (200 mg/kg) (for 56 days),67454,ovariectomy,N-nitrosodiethylamine (200 mg/kg) (for 56 days),,
655,"De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90.",liver integrity trait,,RS:0001296,F344.BN-(D16Mit5-D16Rat75),female,0 days,N/A,,CMO:0001081,volume of liver occupied by tumorous lesions as percentage of total liver volume,,,,69,%,,9.8,MMO:0000220,ex vivo light microscopy with digital image analysis,,0.0,intraperitoneal,N-nitrosodiethylamine injection at 200mg/kg,56,days,ovariectomy then testosterone (3.3 mg/kg) (for 21 days) then N-nitrosodiethylamine (200 mg/kg) (for 56 days) then testosterone (10 mg/kg) (for 35 days),67458,ovariectomy,testosterone (3.3 mg/kg) (for 21 days),N-nitrosodiethylamine (200 mg/kg) (for 56 days),testosterone (10 mg/kg) (for 35 days)
789,"De Miglio MR, et al., Cancer Res 2002 Aug 1;62(15):4459-63.",liver integrity trait,,RS:0000307,F344/Crli,not specified,0 days,20,,CMO:0001081,volume of liver occupied by tumorous lesions as percentage of total liver volume,,,,80.11,%,6.333,28.322,MMO:0000220,ex vivo light microscopy with digital image analysis,,0.0,150mg/Kg body weight,N-nitrosodiethylamine injection,224,days,N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 %) (for 15 days) then partial hepatectomy,67755,N-nitrosodiethylamine (150 mg/kg) ,2-acetamidofluorene (0.02 %) (for 15 days),partial hepatectomy,
789,"De Miglio MR, et al., Cancer Res 2002 Aug 1;62(15):4459-63.",liver integrity trait,,RS:0000135,BN/Crli,not specified,0 days,20,,CMO:0001081,volume of liver occupied by tumorous lesions as percentage of total liver volume,,,,13.69,%,1.99,8.8996,MMO:0000220,ex vivo light microscopy with digital image analysis,,0.0,150mg/Kg body weight,N-nitrosodiethylamine injection,224,days,N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 %) (for 15 days) then partial hepatectomy,67758,N-nitrosodiethylamine (150 mg/kg) ,2-acetamidofluorene (0.02 %) (for 15 days),partial hepatectomy,
950,"Pascale RM, et al., Carcinogenesis. 1996 Aug;17(8):1765-8.",liver integrity trait,,RS:0000313,F344/NRrrc,female,0 days,3,,CMO:0001081,volume of liver occupied by tumorous lesions as percentage of total liver volume,,,,8.92,%,2.85,4.9363,MMO:0000220,ex vivo light microscopy with digital image analysis,,0.0,,N-nitrosodiethtlamine injection,56,days,N-nitrosodiethylamine (150 mg/kg) then controlled 2-acetamidofluorene content diet (0.02 %) (for 14 days) then partial hepatectomy,68619,N-nitrosodiethylamine (150 mg/kg) ,controlled 2-acetamidofluorene content diet (0.02 %) (for 14 days),partial hepatectomy,
950,"Pascale RM, et al., Carcinogenesis. 1996 Aug;17(8):1765-8.",liver integrity trait,,RS:0000113,BN,female,0 days,3,,CMO:0001081,volume of liver occupied by tumorous lesions as percentage of total liver volume,,,,1.61,%,0.46,0.7967,MMO:0000220,ex vivo light microscopy with digital image analysis,,0.0,,N-nitrosodiethtlamine injection,56,days,N-nitrosodiethylamine (150 mg/kg) then controlled 2-acetamidofluorene content diet (0.02 %) (for 14 days) then partial hepatectomy,68620,N-nitrosodiethylamine (150 mg/kg) ,controlled 2-acetamidofluorene content diet (0.02 %) (for 14 days),partial hepatectomy,
912,"De Miglio MR, et al., Cancer Res 1999 Sep 15;59(18):4651-7.",liver integrity trait,,RS:0000363,F344/NHsd,not specified,0 days,12,,CMO:0001081,volume of liver occupied by tumorous lesions as percentage of total liver volume,,,,84.18,%,3.64,12.6093,MMO:0000220,ex vivo light microscopy with digital image analysis,,0.0,,N-nitrosodiethylamine,224,days,N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 %) (for 210 days) then partial hepatectomy,68353,N-nitrosodiethylamine (150 mg/kg) ,2-acetamidofluorene (0.02 %) (for 210 days),partial hepatectomy,
912,"De Miglio MR, et al., Cancer Res 1999 Sep 15;59(18):4651-7.",liver integrity trait,,RS:0000155,BN/SsNHsd,not specified,0 days,7,,CMO:0001081,volume of liver occupied by tumorous lesions as percentage of total liver volume,,,,19.83,%,2.09,5.5296,MMO:0000220,ex vivo light microscopy with digital image analysis,,0.0,,N-nitrosodiethylamine,224,days,N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 %) (for 210 days) then partial hepatectomy,68354,N-nitrosodiethylamine (150 mg/kg) ,2-acetamidofluorene (0.02 %) (for 210 days),partial hepatectomy,